2m 2m 2m 2m 2m 2m 2m
Innate Pharma (IPHYF)
OTC
$1.51-$0.14 (-8.53%)
Price as of Oct 02, 2026- N/AMarket Cap
- -24.54%1-Year Change
- BiotechnologyIndustry
Innate Pharma (IPHYF)
$1.51-$0.14 (-8.53%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$1.51
$1.51
$1.51
1-Year Range
$1.37
$2.25
$1.51
Latest Close$1.51
Change
-$0.14 (-9.33%)
Volume1,000
Information as of 10/02/2026
Company Profile
INNATE PHARMA
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
INNATE PHARMA
Key Executives
- Jonathan E. Dickinson
- Sonia Quaratino
- Yannis Morel
- Stephanie Cornen
- Jean Jacques Fournié
Current Ownership Distribution
- Other93.9M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)